Regulatory | 2cureX

Regulatory Show all

March 1 | 2019

2cureX offentliggör bokslutskommuniké för räkenskapsåret 2018

March 1 | 2019

2cureX publishes year-end report for the fiscal year 2018

February 20 | 2019

Correction – Lack of reference to MAR – 2cureX meddelar positiva resultat från pågående klinisk studie med kraftigt förbehandlade kolorektalcancerpatienter

February 20 | 2019

Correction – Lack of reference to MAR – 2cureX reports positive results from an ongoing clinical trial in heavily pre-treated colorectal cancer patients

January 16 | 2019

2cureX strengthens the organisation via the recruitment of a CFO

January 16 | 2019

2cureX stärker organisationen genom rekrytering av CFO

December 10 | 2018

2cureX is accelerating the launch of IndiTreat®

December 10 | 2018

2cureX accelererar lanseringen av IndiTreat®

November 23 | 2018

2cureX AB publishes interim report for January – September 2018

November 23 | 2018

2cureX AB offentliggör delårsrapport för januari – september 2018

November 16 | 2018

Vejle universitetssjukhus och 2cureX har erhållit godkännande att inleda en klinisk studie i bukspottkörtelcancer

November 16 | 2018

The University Hospital, Vejle Hospital and 2cureX have received approval to start a clinical trial in pancreatic cancer

October 9 | 2018

2cureX announces CE-IVD marking of its IndiTreat test